================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ----------------- FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2006 COMMISSION FILE NO. 000-25064 ----------------- HEALTH FITNESS CORPORATION (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER) MINNESOTA NO. 41-1580506 (STATE OR OTHER JURISDICTION OF (IRS EMPLOYER INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.) 3600 AMERICAN BOULEVARD WEST, BLOOMINGTON, MINNESOTA 55431 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) REGISTRANT'S TELEPHONE NUMBER (952) 831-6830 ----------------- Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ] Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer [ ] Accelerated filer [ ] Non-accelerated filer [x] Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES [ ] NO [x] The number of shares outstanding of the registrant's common stock as of November 10, 2006 was: Common Stock, $0.01 par value, 19,001,771 shares ================================================================================ HEALTH FITNESS CORPORATION CONSOLIDATED FINANCIAL STATEMENTS TABLE OF CONTENTS PAGE PART I. FINANCIAL INFORMATION Item 1. Consolidated Financial Statements (unaudited) Consolidated Balance Sheets as of September 30, 2006 and December 31, 2005 3 Consolidated Statements of Earnings for the three and nine months ended September 30, 2006 and 2005 4 Consolidated Statements of Cash Flows for the nine months ended September 30, 2006 and 2005 5 Notes to Consolidated Financial Statements 6 Item 2. Management's Discussion and Analysis of Financial Condition 12 and Results of Operations Item 3. Quantitative and Qualitative Disclosures About Market Risk 19 Item 4. Controls and Procedures 19 PART II. OTHER INFORMATION 20 Item 1. Legal Proceedings 20 Item 1A. Risk Factors 20 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 20 Item 3. Defaults Upon Senior Securities 20 Item 4. Submission of Matters to a Vote of Security Holders 20 Item 5. Other Information 20 Item 6. Exhibits 20 Signatures 21 Exhibit Index 22 2 HEALTH FITNESS CORPORATION CONSOLIDATED BALANCE SHEETS (UNAUDITED) September 30, December 31, 2006 2005 -------------- ------------- ASSETS CURRENT ASSETS Cash ....................................................................... $ 713,043 $ 1,471,505 Trade and other accounts receivable, less allowances of $180,000 and $200,700 ................................................................ 10,840,104 8,839,046 Prepaid expenses and other ................................................. 1,026,142 509,273 Deferred tax assets ........................................................ 347,700 337,800 -------------- ------------- Total current assets ................................................ 12,926,989 11,157,624 PROPERTY AND EQUIPMENT, net .................................................... 537,521 347,820 OTHER ASSETS Goodwill ................................................................... 13,020,290 12,919,689 Software, less accumulated amortization of $265,500 and $0 ................. 1,774,061 1,762,000 Customer contracts, less accumulated amortization of $1,796,100 and $1,626,100 .............................................................. 18,890 188,889 Trademark, less accumulated amortization of $221,500 and $147,000 .......... 271,620 346,057 Other intangible assets, less accumulated amortization of $149,300 and $88,000 ................................................................. 379,774 441,086 Deferred tax assets ........................................................ 394,760 374,500 Other ...................................................................... 29,604 47,105 -------------- ------------- $ 29,353,509 $ 27,584,770 ============== ============= LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Trade accounts payable ..................................................... $ 874,562 $ 687,125 Accrued salaries, wages, and payroll taxes ................................. 2,144,943 2,693,927 Other accrued liabilities .................................................. 1,009,626 763,115 Accrued self funded insurance .............................................. 344,288 250,000 Deferred revenue ........................................................... 1,681,077 1,868,446 -------------- ------------- Total current liabilities ........................................... 6,054,496 6,262,613 LONG-TERM OBLIGATIONS .......................................................... -- -- COMMITMENTS AND CONTINGENCIES .................................................. -- -- WARRANT OBLIGATION ............................................................. -- 2,210,889 PREFERRED STOCK, $0.01 par value, 10,000,000 shares authorized, 0 and 1,000 shares issued and outstanding .............................................. -- 8,623,546 STOCKHOLDERS' EQUITY Common stock, $0.01 par value; 50,000,000 shares authorized; 19,001,771 and 13,787,349 shares issued and outstanding ................. 190,017 137,874 Additional paid-in capital ................................................. 25,921,323 15,625,425 Accumulated comprehensive income ........................................... (85) 1,245 Accumulated deficit ........................................................ (2,812,242) (5,276,822) -------------- ------------- 23,299,013 10,487,722 -------------- ------------- $ 29,353,509 $ 27,584,770 ============== ============= See notes to consolidated financial statements. 3 HEALTH FITNESS CORPORATION CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED) Three Months Ended Nine Months Ended September 30, September 30, ---------------------------- ---------------------------- 2006 2005 2006 2005 ------------ ------------ ------------ ------------ REVENUE .......................................... $ 16,340,380 $ 13,464,278 $ 46,482,771 $ 40,607,994 COSTS OF REVENUE ................................. 11,061,752 9,965,464 33,439,649 30,216,762 ------------ ------------ ------------ ------------ GROSS PROFIT ..................................... 5,278,628 3,498,814 13,043,122 10,391,232 OPERATING EXPENSES Salaries ..................................... 2,045,284 1,449,297 6,187,653 4,243,782 Other selling, general and administrative ............................ 1,133,118 945,540 3,471,455 2,625,037 Amortization of acquired intangible assets ......................... 96,986 220,095 313,058 659,432 ------------ ------------ ------------ ------------ Total operating expenses .............. 3,275,388 2,614,932 9,972,166 7,528,251 ------------ ------------ ------------ ------------ OPERATING INCOME ................................. 2,003,240 883,882 3,070,956 2,862,981 OTHER INCOME (EXPENSE) Interest expense ............................. (1,681) 4,035 (5,831) (24,214) Change in fair value of warrants ............. -- -- 841,215 -- Other, net ................................... (2,529) (2,404) 7,532 (4,394) ------------ ------------ ------------ ------------ EARNINGS BEFORE INCOME TAXES ..................... 1,999,030 885,513 3,913,872 2,834,373 INCOME TAX EXPENSE ............................... 825,189 354,206 1,352,884 1,133,749 ------------ ------------ ------------ ------------ NET EARNINGS ..................................... 1,173,841 531,307 2,560,988 1,700,624 Dividend to preferred shareholders............ -- 24,819 96,410 68,019 ------------ ------------ ------------ ------------ NET EARNINGS APPLICABLE TO COMMON SHAREHOLDERS.... $ 1,173,841 $ 506,488 $ 2,464,578 $ 1,632,605 ============ ============ ============ ============ NET EARNINGS PER SHARE: Basic ........................................ $ 0.06 $ 0.04 $ 0.14 $ 0.13 Diluted ...................................... $ 0.06 $ 0.03 $ 0.09 $ 0.10 WEIGHTED AVERAGE COMMON SHARES: Basic ........................................ 18,963,948 12,836,971 17,665,550 12,704,035 Diluted ...................................... 19,550,662 16,662,753 19,680,363 16,633,799 See notes to consolidated financial statements. 4 HEALTH FITNESS CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Nine Months Ended September 30, --------------------------- 2006 2005 ----------- ------------ CASH FLOWS FROM OPERATING ACTIVITIES: Net earnings ............................................................. $ 2,464,578 $ 1,700,624 Adjustments to reconcile net earnings to net cash provided by operating activities: Depreciation ......................................................... 383,102 63,786 Amortization ......................................................... 305,747 653,350 Warrant valuation .................................................... (841,215) -- Compensation for stock options ....................................... 341,553 -- Deferred taxes ....................................................... (30,160) 1,046,400 Loss on disposal of assets ........................................... 158 -- Changes in operating assets and liabilities, net of assets acquired: Trade and other accounts receivable ................................ (2,001,058) (280,907) Prepaid expenses and other ......................................... (516,869) (626,622) Other assets ....................................................... 17,501 31,062 Trade accounts payable ............................................. 187,437 (36,728) Accrued liabilities and other ...................................... (209,515) (1,041,812) Deferred revenue ................................................... (187,369) (162,958) ----------- ------------ Net cash provided by (used in) operating activities ......... (86,268) 1,346,195 ----------- ------------ CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment ...................................... (584,863) (104,059) Other .................................................................... (100,599) (7,084) ----------- ------------ Net cash used in investing activities ....................... (685,462) (111,143) ----------- ------------ CASH FLOWS FROM FINANCING ACTIVITIES: Borrowings under note payable ............................................ -- 13,837,389 Repayments of note payable ............................................... -- (15,450,148) Costs from issuance of preferred stock ................................... (161,725) -- Proceeds from issuance of common stock ................................... 171,287 163,008 Proceeds from the exercise of stock options .............................. 3,706 11,428 ----------- ------------ Net cash provided by (used in) financing activities ......... 13,268 (1,438,323) ----------- ------------ NET DECREASE IN CASH ........................................................ (758,462) (203,271) CASH AT BEGINNING OF PERIOD ................................................. 1,471,505 241,302 ----------- ------------ CASH AT END OF PERIOD ....................................................... $ 713,043 $ 38,031 =========== ============ Supplemental cash flow information: Cash paid for interest .......................................... $ 788 $ 30,297 Cash paid for taxes ............................................. 521,640 403,651 Noncash financing activities affecting cash flow: Conversion of warrant liability to additional paid in capital... 1,369,374 -- Dividend to preferred shareholders ............................. -- 68,019 See notes to consolidated financial statements. 5 HEALTH FITNESS CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) NOTE 1. BASIS OF PRESENTATION The accompanying unaudited consolidated financial statements for the three and nine months ended September 30, 2006 have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information. Financial information as of December 31, 2005 has been derived from our audited consolidated financial statements. In accordance with the rules and regulations of the United States Securities and Exchange Commission, the Company has omitted footnote disclosures that would substantially duplicate the disclosures contained in the audited financial statements of the Company. The unaudited consolidated financial statements should be read together with the financial statements for the year ended December 31, 2005, and footnotes thereto included in the Company's Form 10-K as filed with the United States Securities and Exchange Commission on March 30, 2006. In the opinion of management, the interim consolidated financial statements include all adjustments (consisting of normal recurring accruals) necessary for the fair presentation of the results for interim periods presented. These financial statements include some amounts that are based on management's best estimates and judgments. These estimates may be adjusted as more information becomes available, and any adjustment could be significant. The impact of any change in estimate is included in the determination of earnings in the period in which the change in estimate is identified. Operating results for the three and nine months ended September 30, 2006 are not necessarily indicative of the operating results that may be expected for the year ended December 31, 2006. Certain 2006 operating expenses have been reclassified to conform with the presentation of amounts in our Statement of Earnings for the quarter and nine months ended September 30, 2006. These reclassifications had no effect on revenue, net earnings, earnings per share or shareholders' equity as previously reported. NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business - We provide fitness and health management services and programs to corporations, governmental units, hospitals, communities and universities located in the United States and Canada. Fitness and health management services include the development, marketing and management of corporate, hospital, community and university based fitness centers, injury prevention and work-injury management consulting, on-site physical therapy and employee health management services. Programs include wellness and health programs for individual customers, including health risk assessments, biometric screenings, nutrition and weight loss programs, smoking cessation, massage therapy, back care and ergonomic injury prevention. Consolidation - The consolidated financial statements include the accounts of our Company and our wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Cash - We maintain cash balances at several financial institutions, and at times, such balances exceed insured limits. We have not experienced any losses in such accounts and believe we are not exposed to any significant credit risk on cash. At September 30, 2006 and December 31, 2005, we had cash of approximately $8,800 and $24,000 (U.S. Dollars) in a Canadian bank account. Trade and Other Accounts Receivable - Trade and other accounts receivable represent amounts due from companies and individuals for services and products. We grant credit to customers in the ordinary course of business, but generally do not require collateral or any other security to support amounts due. Management performs ongoing credit evaluations of customers. We determine our allowance for discounts and doubtful accounts by considering a 6 number of factors, including the length of time trade accounts receivable are past due, our previous loss history, the customer's current ability to pay its obligation to us, and the condition of the general economy and the industry as a whole. We write off accounts receivable when they become uncollectible, and payments subsequently received on such receivable are credited to the allowance. Concentrations of credit risk with respect to trade receivables are limited due to the large number of customers and their geographic dispersion. Property and Equipment - Property and equipment are stated at cost. Depreciation and amortization are computed using both straight-line and accelerated methods over the useful lives of the assets. Goodwill - Goodwill represents the excess of the purchase price and related costs over the fair value of net assets of businesses acquired. The carrying value of goodwill is not amortized, but is tested for impairment on an annual basis or when factors indicating impairment are present. Projected discounted cash flows are used in assessing these assets. We elected to complete the annual impairment test of goodwill on December 31 of each year and determined that our goodwill relates to one reporting unit for purposes of impairment testing. Intangible Assets - Our intangible assets include customer contracts, trademarks and tradenames, software and other intangible assets, all of which are amortized on a straight-line basis. Customer contracts represent the fair value assigned to acquired management contracts, which are amortized over the remaining life of the contracts. Trademark and tradenames represent the value assigned to acquired trademarks and tradenames, and are amortized over a period of five years. Software represents the value assigned to an acquired web-based software program and is amortized over a period of five years. Other intangible assets include the value assigned to acquired customer lists, which is amortized over a period of six years, as well as deferred financing costs, which are amortized over the term of the related credit agreement. Revenue Recognition - Revenue is recognized at the time the service is provided to the customer. We determine our allowance for discounts by considering historical discount history and current payment practices of our customers. For annual contracts, monthly amounts are recognized ratably over the term of the contract. Certain services provided to the customer may vary on a periodic basis and are invoiced to the customer in arrears. The revenues relating to these services are estimated in the month the service is performed based on the cost of the services. Amounts received from customers in advance of providing the services of the contract are recorded as deferred revenue and recognized when the services are provided. We have contracts with third-parties to provide ancillary services in connection with their fitness and wellness management services and programs. Under such arrangements, the third-parties invoice and receive payments from us based on transactions with the ultimate customer. We do not recognize revenues related to such transactions as the ultimate customer assumes the risk and rewards of the contract and the amounts billed to the customer are either at cost or with a fixed markup. Amounts received from new customers for website activation fees are treated as deferred revenue and recognized over a period of three years, which is the estimated life of a new customer. Valuation of Derivative Instruments - In accordance with the interpretive guidance in EITF Issue No. 05-4, "The Effect of a Liquidated Damages Clause on a Freestanding Financial Instrument Subject to EITF Issue No. 00-19, "Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company's Own Stock", we value warrants we issued in November 2005 in our financing transaction as a derivative liability. We must make certain periodic assumptions and estimates to value the derivative liability. Factors affecting the amount of this liability include changes in our stock price, the computed volatility of our stock price and other assumptions. The change in value is reflected in our statements of operations as non-cash income or expense, and the changes in the carrying value of derivatives can have a material impact on our financial statements. For the quarter and nine months ended September 30, 2006, we recognized non-cash income of $0 and $841,215, respectively, upon 7 revaluation of certain warrants that are subject to this accounting treatment. The derivative liability associated with these warrants is reflected on our balance sheet as of December 31, 2005 as a long-term liability. On June 15, 2006, we reached an agreement with the investors owning these warrants to amend the terms of the investment documents, which resulted in the warrants to be reflected as equity. As a result of this accounting change, we made a final valuation of our warrant liability on June 15, 2006, which resulted in non-cash income of $406,694 for our second quarter, and the remaining warrant liability of $1,369,674 was reclassified to additional paid in capital. We are no longer required to revalue these warrants on a prospective basis. Comprehensive Income - Comprehensive income represents net earnings adjusted for foreign currency translation adjustments. Total comprehensive income was $2,559,658 and $1,704,882 for the nine months ended September 30, 2006 and 2005. Net Earnings Per Share - Basic net earnings per share is computed by dividing net earnings applicable to common shareholders by the number of weighted average common shares outstanding. For the three and nine months ended September 30, 2006, diluted net earnings per share is computed by dividing net earnings applicable to common shareholders, plus dividends to preferred shareholders (net earnings), less the non-cash benefit related to a change in fair value of warrants by the number of weighted average common shares outstanding, and common share equivalents relating to stock options, stock warrants, and stock warrants accounted for as a liability, if dilutive. For the three and nine months ended September 30, 2005, diluted net earnings per share is computed by dividing net earnings applicable to common shareholders, plus dividends to preferred shareholders (net earnings) by the number of weighted average common shares outstanding, and common share equivalents relating to stock options and stock warrants, if dilutive. Refer to Exhibit 11.0 attached hereto for a detail computation of earnings per share. Common stock options and warrants to purchase 2,807,156 and 584,163 shares of common stock were excluded from the calculation for the three months ended September 30, 2006 and 2005, and 2,425,806 and 481,298 were excluded from the calculation for the nine months ended September 30, 2006 and 2005 because their exercise price exceeded the average trading price of the Company's common stock during each of the periods. Stock-based Compensation - We maintain a stock option plan for the benefit of certain eligible employees and directors of the Company. We have authorized 4,000,000 shares for grant under our 2005 Stock Option Plan, and a total of 1,260,400 shares of common stock are reserved for additional grants of options at September 30, 2006. Our stock options generally vest ratably over four years of service and have a contractual life of 6 years. During the quarter ended September 30, 2006, we recorded compensation expense of $32,000 for 20,000 shares of common stock that was granted to a newly appointed member of our board of directors. Such grant was in accordance with our director compensation plan. Commencing January 1, 2006, we adopted Statement of Financial Accounting Standard No. 123R, "Share Based Payment" ("SFAS 123R"), which requires all share-based payments, including grants of stock options, to be recognized in the income statement as an operating expense, based on their fair values over the requisite service period. The compensation cost we record for these awards will be based on their grant date fair value as calculated for the proforma disclosures required by Statement 123. We recorded $71,150 and $309,553 of stock option compensation expense, included in salaries within our operating expenses section, for the three and nine months ended September 30, 2006. We also recorded a deferred tax benefit of $28,460 and $123,822 for the three and nine months ended September 30, 2006 in connection with recording this non-cash expense. This deferred tax benefit will be adjusted based upon the actual tax benefit realized from the exercise of the underlying stock options. The compensation expense reduced diluted earnings per share by less than $0.01 for the three months ended September 30, 2006, and by approximately $0.02 for the nine months ended September 30, 2006. As of September 30, 2006, approximately $726,000 of total unrecognized compensation costs related to non-vested awards is expected to be recognized over a weighted average period of approximately 2.77 years. 8 Prior to adopting SFAS 123R, we accounted for stock-based compensation under Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees." We have applied the modified prospective method in adopting SFAS 123R. Accordingly, periods prior to adoption have not been restated. The following table summarizes information about stock options at September 30, 2006: Options Outstanding Options Exercisable --------------------------------------------------- ------------------------- Weighted Average Weighted Weighted Remaining Average Average Range of Number Contractual Life Exercise Number Exercise Exercise Prices Outstanding In Years Price Exercisable Price --------------- ------------- ---------------------- --------- ----------- --------- $0.30 - $0.39 405,400 1.26 $0.33 364,675 $0.33 0.47 - 0.69 596,650 1.95 0.56 596,650 0.56 0.95 - 1.25 279,000 4.15 1.17 162,000 1.15 1.26 - 2.27 459,350 4.35 1.86 342,550 1.81 2.28 - 3.00 813,375 4.13 2.74 369,500 2.79 --------- --------- 2,553,775 3.21 $1.52 1,835,375 $1.25 ========= ========= We use the Black-Scholes option pricing model to determine the weighted average fair value of options. The weighted average fair value of options granted during the three month periods ended September 30, 2006 and 2005 were $0.73 and $0.87, respectively. The fair value of options at date of grant and the assumptions utilized to determine such values are indicated in the following table: Three Months Ended September 30, --------------------- 2006 2005 ---- ---- Risk-free interest rate ........................... 4.57% 3.45% Expected volatility ............................... 54.8% 61.0% Expected life (in years) .......................... 3.78 2.71 Dividend yield .................................... -- -- Option transactions under the 2005 Stock Option Plan during the third quarter ended September 30, 2006 are summarized as follows: Weighted Weighted Average Aggregate Average Exercise Intrinsic Remaining Options Price Value Term --------- --------- ---------- --------- Outstanding at June 30, 2006 .......... 2,607,825 $ 1.55 Granted ............................... 40,000 $ 1.60 Exercised ............................. -- -- Canceled/Forfeited .................... (94,050) 2.45 --------- --------- ---------- --------- Outstanding at September 30, 2006 ..... 2,553,775 $ 1.52 $1,237,446 2.99 Exercisable at September 30, 2006 ..... 1,835,375 $ 1.25 $1,142,423 2.40 9 Option transactions under the 2005 Stock Option Plan during the nine months ended September 30, 2006 are summarized as follows: Weighted Weighted Average Aggregate Average Exercise Intrinsic Remaining Options Price Value Term --------- -------- ----------- --------- Outstanding at December 31, 2005 .... 2,157,425 $ 1.34 Granted ............................. 495,500 $ 2.44 Exercised ........................... (3,850) $ 0.96 Canceled/Forfeited .................. (95,300) $ 2.43 --------- -------- ----------- --------- Outstanding at September 30, 2006 ... 2,553,775 $ 1.52 $ 1,237,446 2.99 Exercisable at September 30, 2006 ... 1,835,375 $ 1.25 $ 1,142,423 2.40 The were no options exercised during the quarter ended September 30, 2006. The total number of options that vested during the quarter ended September 30, 2006 was 17,500 with a fair value of $9,725. Fair Values of Financial Instruments - Due to their short-term nature, the carrying value of our current financial assets and liabilities approximates their fair values. The fair value of long-term obligations, if recalculated based on current interest rates, would not significantly differ from the recorded amounts. Use of Estimates - Preparing consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. NOTE 3. FINANCING On November 14, 2005 (the "Effective Date"), in a Private Investment in Public Equity transaction (the "PIPE Transaction"), we issued an aggregate of 1,000 shares of Series B Convertible Preferred Stock (the "Series B Stock"), together with warrants to purchase 1,530,000 shares of common stock at $2.40 per share, to a limited number of accredited investors for aggregate gross proceeds of $10.2 million. After selling commissions and expenses, we received net proceeds of approximately $9.4 million. The Series B Stock automatically converted into 5,100,000 shares of our common stock on March 10, 2006, the date the Securities and Exchange Commission (the "SEC") first declared effective a registration statement covering these shares. Each share of Series B Stock was entitled to a number of votes equal to the number of shares of common stock into which it was then convertible. Except as required by law, holders of Series B Stock were entitled to vote together as one class with holders of common stock. Each share of Series B Stock had a stated dividend rate of 5% per year calculated based upon the initial share issuance price of $10,200. We used the proceeds from this PIPE Transaction to redeem our Series A Convertible Preferred Stock and to fund the acquisition of HealthCalc.Net, Inc. In accordance with the terms of the PIPE Transaction, we were required to file with the SEC, within sixty (60) days from the Effective Date, a registration statement covering the common shares issued and issuable in the PIPE Transaction. We were also required to cause the registration statement to go effective on or before the expiration of one hundred twenty (120) days from the Effective Date. We would have been subject to liquidated damages of one percent (1%) per month of the aggregate gross proceeds ($10,200,000), if we failed to meet these date requirements. On March 10, 2006, the SEC declared effective our Form S-1 registration statement and, as a result, we did not pay any liquidated damages for failure to meet the filing and effectiveness date requirements. We could nevertheless be subject to the foregoing liquidated damages if we fail to maintain the effectiveness of the registration statement. On June 15, 2006, we entered into an agreement with the accredited investors to amend the Registration Rights Agreement to cap the amount of liquidated damages we could pay at 9% of the aggregate purchase price paid by each accredited investor. 10 The warrants, which were issued together with the Series B Stock, have a term of five years, and give the investors the option to require us to repurchase the warrants for a purchase price, payable in cash within five (5) business days after such request, equal to the Black Scholes value of any unexercised warrant shares, only if, while the warrants are outstanding, any of the following change in control transactions occur: (i) we effect any merger or consolidation, (ii) we effect any sale of all or substantially all of our assets, (iii) any tender offer or exchange offer is completed whereby holders of our common stock are permitted to tender or exchange their shares for other securities, cash or property, or (iv) we effect any reclassification of our common stock whereby it is effectively converted into or exchanged for other securities, cash or property. On June 15, 2006, we entered into an agreement with the accredited investors to amend the Warrant Agreement to give us the ability to repurchase the warrants, in the case of a change in control transaction, using shares of stock, securities or assets, including cash. Under EITF 00-19 "Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company's Own Stock" (EITF 00-19"), the fair value of the warrants issued under the PIPE Transaction have been reported as a liability due to the requirement to net-cash settle the transaction. There are two reasons for this treatment: (i) there are liquidated damages, payable in cash, of 1% of the gross proceeds per month ($102,000) should we fail (subject to certain permitted circumstances) to maintain effectiveness of the registration statement in accordance with the PIPE Transaction; and (ii) the investors may put their warrants back to us for cash if a change in control transaction that meets the definition previously discussed occurs. On June 15, 2006, we reached an agreement with the investors owning these warrants to amend the terms of the investment documents, which resulted in the warrants to be reflected as equity. As a result of this accounting change, we made a final valuation of our warrant liability on June 15, 2006, which resulted in non-cash income of $406,694 for our second quarter, and the remaining warrant liability of $1,369,674 was reclassified to additional paid in capital. We are no longer required to revalue these warrants on a prospective basis. NOTE 4. INCOME TAXES The Company records income taxes in accordance with the liability method of accounting. Deferred income taxes are provided for temporary differences between the financial reporting and tax basis of assets and liabilities and federal operating loss carryforwards. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of the enactment. We do not record a tax liability or benefit in connection with the change in fair value of certain of our warrants. Income taxes are calculated based on management's estimate of the Company's effective tax rate, which takes into consideration a federal tax rate of 34% and an effective state tax rate of 6%. 11 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our interim consolidated financial statements and related notes included in Item 1 of Part 1 of this Quarterly Report, and the audited consolidated financial statements and notes thereto and Management's Discussion and Analysis of Financial Condition and Results of Operations contained in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2005. CRITICAL ACCOUNTING POLICIES. Our most critical accounting policies, which are those that require significant judgment, include: revenue recognition, trade and other accounts receivable, goodwill and stock-based compensation. A more in-depth description of these can be found in Note 2 to the interim consolidated financial statements included in this Quarterly Report and our Annual Report on Form 10-K for the fiscal year ended December 31, 2005. GENERAL. We provide fitness and health management services and programs to corporations, governmental units, hospitals, communities and universities located in the United States and Canada. Fitness and health management services include the development, marketing and management of corporate, hospital, community and university based fitness centers, injury prevention and work-injury management consulting, on-site physical therapy and employee health management services. Programs include wellness and health programs for individual customers, including health risk assessments, biometric screenings, nutrition and weight loss programs, smoking cessation, massage therapy, back care and ergonomic injury prevention. RESULTS OF OPERATIONS The following table sets forth our statement of operations data as a percentage of total revenues and also sets forth other financial and operating data for the three and nine months ended September 30, 2006 and 2005: Three Months Ended Nine Months Ended September 30, September 30, ------------------ ----------------- 2006 2005 2006 2005 ----- ----- ----- ----- REVENUE............................................ 100.0% 100.0% 100.0% 100.0% COSTS OF REVENUE................................... 67.7 74.0 71.9 74.4 ----- ----- ----- ----- GROSS PROFIT....................................... 32.3 26.0 28.1 25.6 ----- ----- ----- ----- OPERATING EXPENSES Salaries ...................................... 12.5 10.8 13.3 10.4 Other selling, general and administrative...... 6.9 7.0 7.5 6.5 Amortization of acquired intangible assets..... 0.6 1.6 0.7 1.6 ----- ----- ----- ----- Total operating expenses ............... 20.0 19.4 21.5 18.5 ----- ----- ----- ----- OPERATING INCOME .................................. 12.3 6.6 6.6 7.1 OTHER INCOME (EXPENSE) ............................ -- -- 1.8 (0.1) ----- ----- ----- ----- EARNINGS BEFORE INCOME TAXES ...................... 12.3 6.6 8.4 7.0 INCOME TAX EXPENSE ................................ 5.1 2.6 2.9 2.8 ----- ----- ----- ----- NET EARNINGS ...................................... 7.2 4.0 5.5 4.2 Dividend to preferred shareholders ............ -- 0.2 0.2 0.2 ----- ----- ----- ----- NET EARNINGS APPLICABLE TO COMMON SHAREHOLDERS ........................... 7.2% 3.8% 5.3% 4.0% ===== ===== ===== ===== 12 OTHER FINANCIAL AND OPERATING DATA: Three Months Ended Nine Months Ended September 30, September 30, ------------------------- ------------------------- 2006 2005 2006 2005 ----------- ----------- ----------- ----------- Fitness Management Revenue Staffing Services......................... $10,089,452 $ 9,446,042 $29,781,528 $28,490,918 Program and Consulting Services........... 571,746 495,537 1,797,554 1,612,410 ----------- ----------- ----------- ----------- 10,661,198 9,941,579 31,579,082 30,103,328 ----------- ----------- ----------- ----------- Health Management Revenue Staffing Services......................... 3,692,693 3,040,491 10,068,096 9,139,830 Program and Consulting Services........... 1,986,489 482,208 4,835,593 1,364,835 ----------- ----------- ----------- ----------- 5,679,182 3,522,699 14,903,689 10,504,665 ----------- ----------- ----------- ----------- Total Revenue Staffing Services......................... 13,782,145 12,486,533 39,849,624 37,630,748 Program and Consulting Services........... 2,558,235 977,745 6,633,147 2,977,245 ----------- ----------- ----------- ----------- $16,340,380 $13,464,278 $46,482,771 $40,607,993 ----------- ----------- ----------- ----------- The following tables set forth certain reclassifications we made to operating expenses for our first and second quarters ending March 31 and June 30, 2006, to conform with the operating expense presentation for our three and nine months ended September 30, 2006. Specifically, we made reclassifications for salaries related to the employees of HealthCalc, a company we acquired in December 2005, from other selling, general and administrative expenses to salaries expense for the quarters ending March 31 and June 30, 2006. These reclassifications had no effect on revenue, net earnings, earnings per share or shareholders' equity as previously reported. For the Three Months Ended ----------------------------------------------------- March 31, March 31, June 30, June 30, 2006 2006 2006 2006 ----------- ------------ ----------- ------------ OPERATING EXPENSES As Reported Reclassified As Reported Reclassified ----------- ------------ ----------- ------------ Salaries ...................................... $1,678,834 $1,995,899 $1,805,533 $2,146,470 Other selling, general and administrative...... 1,436,241 1,119,176 1,560,098 1,219,161 Amortization of acquired intangible assets..... 108,462 108,462 107,610 107,610 --------- --------- --------- --------- Total operating expenses ................... $3,223,537 $3,223,537 $3,473,241 $3,473,241 --------- --------- --------- --------- For the Six Months Ended ------------------------- June 30, June 30, 2006 2006 ----------- ------------ OPERATING EXPENSES As Reported Reclassified ----------- ------------ Salaries ..................................... $3,484,367 $4,142,369 Other selling, general and administrative..... 2,996,339 2,338,337 Amortization of acquired intangible assets.... 216,072 216,072 --------- --------- Total operating expenses .................. $6,696,778 $6,696,778 --------- --------- 13 RESULTS OF OPERATIONS FOR THE QUARTER ENDED SEPTEMBER 30, 2006 AS COMPARED TO THE QUARTER ENDED SEPTEMBER 30, 2005. REVENUE. Revenues increased $2,876,000, or 21.4%, to $16,340,000 for the three months ended September 30, 2006, from $13,464,000 for the three months ended September 30, 2005. This increase is attributable to revenue growth of $2,363,000 from new contracts and incremental business from existing contracts, in addition to revenue growth of $513,000 from HealthCalc, a company we acquired in December 2005. For the third quarter, health management revenue grew 61.2% and fitness management grew 7.2% over the same period last year. During the third quarter of 2006, we won two new contracts within our Health Management business, which may realize annualized incremental revenue of approximately $960,000. Within our Fitness Management business, we won three new contracts, which may realize annualized incremental revenue of approximately $455,000. The value of our new and expanded contracts is a forward looking statement, is based upon an estimate of the anticipated annualized incremental revenue, and should be used only as an indication of the sales activity we have experienced in our two business areas. These estimates should not be considered an indication of the total incremental revenue growth we expect to generate in 2006, or in any year, as actual growth may differ from these estimates due to actual staffing levels, participation rates and contract duration, in addition to other revenue we may lose due to contract termination. GROSS PROFIT. Gross profit increased $1,780,000, or 50.8%, to $5,279,000 for the three months ended September 30, 2006, from $3,499,000 for the three months ended September 30, 2005. This increase is due primarily to the revenue growth within our Health Management business area. Gross profit for the three months ended September 30, 2006 and 2005 also includes a refund of $313,000 and $225,000, respectively, for workers compensation premiums we paid for our 2005 and 2004 plan years. As a percent of revenue, gross profit increased to 32.3%, from 26.0% for the third quarter of 2005. This increase is due primarily to the new health management business we have recently won. Excluding the effect of the workers compensation premium refunds noted above, gross profit as a percent of revenue would be 30.4% for the third quarter of 2006, compared to 24.3% for the third quarter of 2005. OPERATING EXPENSES. Operating expenses increased $660,000, or 25.2%, to $3,275,000 for the three months ended September 30, 2006, from $2,615,000 for the three months ended September 30, 2005. Of this increase, approximately $395,000 is attributed to salaries, operating expenses and asset depreciation related to our acquisition of HealthCalc. In addition, we incurred approximately $103,000 of expense in the third quarter of 2006, including $32,000 of expense related to a grant of stock to a new director, and $71,000 of stock option compensation expense in connection with our adoption of SFAS 123R on January 1, 2006. The remaining cost increase of $162,000 is primarily due to additional staff we hired since late 2005 to execute our health management business plan. We expect to continue incurring these costs at varying levels on a quarterly basis. These expense increases were partially offset by a decrease in amortization expense related to a prior acquisition. OTHER INCOME AND EXPENSE. We had interest expense of $2,000 for the third quarter of 2006, compared to interest income $4,000 for the third quarter of 2005. The cost of borrowed funds for both periods was inconsequential. INCOME TAXES. Income tax expense increased $471,000 to $825,000 for the three months ended September 30, 2006, compared to $354,000 for the same period in 2005. The increase is primarily due to a 125.7% increase in earnings before income taxes, adjusted for changes in permanent and temporary timing differences between book and tax balances for stock option expense, change in fair value of warrants, depreciation and amortization, prepaid expenses and vacation accruals. 14 NET EARNINGS APPLICABLE TO COMMON SHAREHOLDERS. As a result of the above, and the cessation of dividends payable to preferred shareholders, net earnings applicable to common shareholders for the three months ended September 30, 2006 increased $668,000, or 132.0%, to $1,174,000, from $506,000 for the three months ended September 30, 2005. RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2006 AS COMPARED TO THE NINE MONTHS ENDED SEPTEMBER 30, 2005. REVENUE. Revenues increased $5,875,000, or 14.5%, to $46,483,000 for the nine months ended September 30, 2006, from $40,608,000 for the nine months ended September 30, 2005. This increase is attributable to revenue growth of $4,385,000 from new contracts and incremental business from existing contracts, in addition to revenue growth of $1,489,000 from HealthCalc. For the first nine months, health management revenue grew 41.9% and fitness management grew 4.9% over the same period last year. During the first nine months of 2006, we have won twenty-eight new contracts, and expanded five existing contracts in our Health Management business area, which may realize annualized incremental revenue of approximately $7.4 million. In Fitness Management, we have won ten new contracts, and expanded one existing contract, which may realize annualized incremental revenue of $3.2 million. The combined total for new, annualized revenue will be offset by a potential annualized revenue loss of $1.2 million from contract cancellations through our first nine months ended September 30, 2006. The value of our new and expanded contracts is a forward looking statement, is based upon an estimate of the anticipated annualized incremental revenue, and should be used only as an indication of the sales activity we have recently experienced in our two business areas. These estimates should not be considered an indication of the total incremental revenue growth we expect to generate in 2006, or in any year, as actual growth may differ from these estimates due to actual staffing levels, participation rates and contract duration, in addition to other revenue we may lose due to contract termination. GROSS PROFIT. Gross profit increased $2,652,000, or 25.5%, to $13,043,000 for the nine months ended September 30, 2006, from $10,391,000 for the nine months ended September 30, 2005. This increase is due primarily to our revenue growth within our Health Management business area. Gross profit for the nine months ended September 30, 2006 and 2005 also includes a refund of $313,000 and $225,000, respectively, for workers compensation premiums we paid for our 2005 and 2004 plan years. As a percent of revenue, gross profit increased to 28.1%, from 25.6% for the nine months ended September 30, 2005. This increase is due primarily to the new health management business we have recently won. Excluding the effect of the workers compensation premium refunds noted above, gross profit as a percent of revenue would be 27.4% for the first nine months of 2006, compared to 25.0% for the first nine months of 2005. OPERATING EXPENSES. Operating expenses increased $2,444,000, or 32.5%, to $9,972,000 for the nine months ended September 30, 2006, from $7,528,000 for the nine months ended September 30, 2005. Of this increase, approximately $1,278,000 is due to salaries, operating expenses and asset depreciation related to our acquisition of HealthCalc. In addition, we incurred approximately $342,000 of expense in the third quarter of 2006, including $32,000 of expense related to a grant of stock to a new director, and $310,000 of stock option compensation expense in connection with our adoption of SFAS 123R on January 1, 2006. The remaining cost increase of $824,000 is primarily due to additional staff we hired during 2005 and 2006 to execute our health management business plan. We expect to continue incurring these costs at varying levels on a quarterly basis. These expense increases were partially offset by a decrease in amortization expense related to a prior acquisition. OTHER INCOME AND EXPENSE. Interest expense decreased $18,000 to $6,000 for the nine months ended September 30, 2006, compared to $24,000 for the same period in 2005. This decrease is due to the repayment of our Wells 15 Fargo credit line. For the nine months ended September 30, 2006, we recorded an $841,000 non-cash benefit related to a change in fair value for 1,530,000 warrants we issued in connection with the sale of $10.2 million of our Series B Convertible Preferred Stock in November 2005. Refer to the section titled "Summary of Significant Accounting Policies," Valuation of Derivative Instruments, contained elsewhere in this document for further discussion of the accounting we used to value these warrants. INCOME TAXES. Income tax expense increased $219,000 to $1,353,000 for the nine months ended September 30, 2006, compared to $1,134,000 for the same period in 2005. The increase is due primarily to the growth of our operating income. NET EARNINGS APPLICABLE TO COMMON SHAREHOLDERS. As a result of the above changes, which were partially offset by an increase in dividends paid to preferred shareholders, net earnings applicable to common shareholders for the nine months ended September 30, 2006 increased $832,000, or 51.0%, to $2,465,000, from $1,633,000 for the nine months ended September 30, 2005. LIQUIDITY AND CAPITAL RESOURCES The Company's working capital increased $1,977,000 to $6,872,000 at September 30, 2006, compared to working capital of $4,895,000 at December 31, 2005. The increase in working capital is due primarily to an increase in trade and other accounts receivable and prepaid expense, and decreases in trade accounts payable, other accrued liabilities and deferred revenue. These were offset by a decrease in cash and increases to accrued salaries and accrued self funded insurance. In addition to cash flows generated from operating activities, our other primary source of liquidity and working capital is provided by a $7,500,000 Credit Agreement with Wells Fargo Bank, N.A. (the "Wells Loan"). At our option, the Wells Loan bears interest at prime, or the one-month LIBOR plus a margin of 2.25% to 2.75% based upon our Senior Leverage Ratio (effective rate of 8.25% and 7.25% at September 30, 2006 and December 31, 2005). The availability of the Wells Loan decreases $250,000 on the last day of each calendar quarter, beginning September 30, 2003, and matures on September 30, 2008, as amended. Working capital advances from the Wells Loan are based upon a percentage of our eligible accounts receivable, less any amounts previously drawn. The facility provided maximum borrowing capacity of $4,250,000 and $5,000,000 at September 30, 2006 and December 31, 2005, which was available for borrowing on such respective dates. All borrowings are collateralized by substantially all of our assets. At September 30, 2006, we were in compliance with all of our financial covenants. On November 14, 2005 (the "Effective Date"), in a Private Investment in Public Equity transaction (the "PIPE Transaction"), we issued an aggregate of 1,000 shares of Series B Convertible Preferred Stock (the "Series B Stock"), together with warrants to purchase 1,530,000 shares of common stock at $2.40 per share, to a limited number of accredited investors for aggregate gross proceeds of $10.2 million. After selling commissions and expenses, we received net proceeds of approximately $9.4 million. The Series B Stock automatically converted into 5,100,000 shares of our common stock on March 10, 2006, the date the Securities and Exchange Commission (the "SEC") first declared effective a registration statement covering these shares. We used the proceeds from this PIPE Transaction to redeem our Series A Convertible Preferred Stock and to fund the acquisition of HealthCalc.Net, Inc. In accordance with the terms of the PIPE Transaction, we were required to file with the SEC, within sixty (60) days from the Effective Date, a registration statement covering the common shares issued and issuable in the PIPE Transaction. We were also required to cause the registration statement to be declared effective on or before the expiration of one hundred twenty (120) days from the Effective Date. We would have been subject to liquidated 16 damages of one percent (1%) per month of the aggregate gross proceeds ($10,200,000), if we failed to meet these date requirements. On March 10, 2006, the SEC declared effective our registration statement and, as a result, we did not pay any liquidated damages for failure to meet the filing and effectiveness date requirements. We could nevertheless be subject to the foregoing liquidated damages if we fail (subject to certain permitted circumstances) to maintain the effectiveness of the registration statement. On June 15, 2006, we entered into an agreement with the accredited investors to amend the Registration Rights Agreement to cap the amount of liquidated damages we could pay at 9% of the aggregate purchase price paid by each accredited investor. The warrants, which were issued together with the Series B Stock, have a term of five years, and give the investors the option to require us to repurchase the warrants for a purchase price, payable in cash within five (5) business days after such request, equal to the Black Scholes value of any unexercised warrant shares, only if, while the warrants are outstanding, any of the following change in control transactions occur: (i) we effect any merger or consolidation, (ii) we effect any sale of all or substantially all of our assets, (iii) any tender offer or exchange offer is completed whereby holders of our common stock are permitted to tender or exchange their shares for other securities, cash or property, or (iv) we effect any reclassification of our common stock whereby it is effectively converted into or exchanged for other securities, cash or property. On June 15, 2006, we entered into an agreement with the accredited investors to amend the Warrant Agreement to give us the ability to repurchase the warrants, in the case of a change in control transaction, using shares of stock, securities or assets, including cash. Under EITF 00-19 "Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company's Own Stock" (EITF 00-19"), the fair value of the warrants issued under the PIPE Transaction have been reported as a liability due to the requirement to net-cash settle the transaction. There are two reasons for this treatment: (i) there are liquidated damages, payable in cash, of 1% of the gross proceeds per month ($102,000) should we fail to maintain effectiveness of the registration statement in accordance with the PIPE Transaction; and (ii) our investors may put their warrants back to us for cash if we initiate a change in control that meets the definition previously discussed. As a result of the agreement amendments we structured with the accredited investors on September 15, 2006, we were allowed to account for the warrants as equity. On June 15, 2006, we reached an agreement with the investors owning these warrants to amend the terms of the investment documents, which resulted in the warrants to be reflected as equity. As a result of this accounting change, we made a final valuation of our warrant liability on June 15, 2006, which resulted in non-cash income of $406,694 for our second quarter, and the remaining warrant liability of $1,369,674 was reclassified to additional paid in capital. We are no longer required to revalue these warrants on a prospective basis. OFF-BALANCE SHEET ARRANGEMENTS As of September 30, 2006, we have no off-balance sheet arrangements or transactions with unconsolidated, limited purpose entities. We believe that sources of capital to meet future obligations over the next 12 months will be provided by cash generated through operations and our Wells Loan. Currently, we do not have plans to make any significant investments in capital assets or any other one-time expenses that may affect our cash flows from investing activities. We do not believe that inflation has had a significant impact on the results of our operations. PRIVATE SECURITIES LITIGATION REFORM ACT The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Such "forward-looking" information is included in this Form 10-Q, including the MD&A section, as well as in our Annual Report on Form 10-K for the year ended December 31, 2005 that was filed with the Securities and 17 Exchange Commission, and in other materials filed or to be filed by the Company with the Securities and Exchange Commission (as well as information included in oral statements or other written statements made or to be made by the Company). Forward-looking statements include all statements based on future expectations and specifically include, among other things, all statements relating to increasing revenue, improving margins, growth of the market for corporate, hospital, community and university-based fitness centers, the development of new business models, our ability to expand our programs and services and the sufficiency of our liquidity and capital resources. Any statements that are not based upon historical facts, including the outcome of events that have not yet occurred and our expectations for future performance, are forward-looking statements. The words "believe," "estimate," "expect," "intend," "may," "could," "will," "plan," "anticipate," and similar words and expressions are intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of our management. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of the Company. These risks and uncertainties include, but are not limited to those matters identified and discussed in Part II, Item 1A of this Form 10-Q (if any), and in Item 1 of the Company's Form 10-K for the year ended December 31, 2005 under "Risk Factors/Forward-Looking Statements." RECENT ACCOUNTING PRONOUNCEMENTS In June 2006, the FASB ratified the consensus reached by the Emerging Issues Task Force on Issue No. 06-3, "How Sales Taxes Collected From Customers and Remitted to Governmental Authorities Should Be Presented in the Income Statement" ("EITF 06-3"). EITF 06-3 requires a company to disclose its accounting policy (i.e. gross vs. net basis) relating to the presentation of taxes within the scope of EITF 06-3. Furthermore, for taxes reported on a gross basis, an enterprise should disclose the amounts of those taxes in interim and annual financial statements for each period for which an income statement is presented. The guidance is effective for all periods beginning after December 15, 2006. We are currently in the process of assessing the impact the adoption of EITF 06-3 will have on our financial position and results of operation. In July 2006, the FASB issued FASB Interpretation No. 48 ("FIN 48"), "Accounting for Uncertainty in Income Taxes - an interpretation of FASB Statement 109." FIN 48 prescribes a comprehensive model for recognizing, measuring, presenting and disclosing in the financial statements, tax positions taken or expected to be taken on a tax return, including the decision whether to file or not to file in a particular jurisdiction. FIN 48 is effective for fiscal years beginning after December 15, 2006. If there are changes in net assets as a result of application of FIN 48, these changes will be accounted for as an adjustment to retained earnings. We are currently assessing the impact of FIN 48 on our consolidated financial position and results of operations. In September 2006, the FASB issued SFAS 157, "Fair Value Measurements." SFAS 157 does not address "what" to measure at fair value; instead, it addresses "how" to measure fair value. SFAS 157 applies (with limited exceptions) to existing standards that require assets or liabilities to be measured at fair value. SFAS 157 establishes a fair value hierarchy, giving the highest priority to quoted prices in active markets and the lowest priority to unobservable data and requires new disclosures for assets and liabilities measured at fair value based on their level in the hierarchy. SFAS 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007. We are currently evaluating the impact of adopting SFAS 157. In September 2006, the FASB issued SFAS 158, "Employer's Accounting for Defined Benefit Pension and Other Postretirement Plans, an Amendment of SFAS No. 87, 88, 106 and 132R." SFAS 158 requires an employer to (i) recognize in its statement of financial position an asset for a plan's over funded status or a liability for a plan's under funded status; (ii) measure a plan's assets and its obligations that determine its funded status as of the end of the employer's fiscal year (with limited exceptions); and (iii) recognize changes in the funded status of a defined benefit postretirement plan in the year in which the changes occur. Those changes will be reported in 18 comprehensive income of a business entity. The requirement to recognize the funded status of a benefit plan and the disclosure requirements are effective as of the end of the fiscal year ending after December 15, 2006, for entities with publicly traded equity securities, and at the end of the fiscal year ending after June 15, 2007, for all other entities. The requirement to measure plan assets and benefit obligations as of the date of the employer's fiscal year-end statement of financial position is effective for fiscal years ending after December 15, 2008. We do not believe that the adoption of SFAS 158 on January 1, 2007 will have a material effect on our consolidated financial statements. In September 2006, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 108 ("SAB 108"), which becomes effective beginning on January 1, 2007. SAB 108 provides guidance on the consideration of the effects of prior period misstatements in quantifying current year misstatements for the purpose of a materiality assessment. SAB 108 requires an entity to evaluate the impact of correcting all misstatements, including both the carryover and reversing effects of prior year misstatements, on current year financial statements. If a misstatement is material to the current year financial statements, the prior year financial statements should also be corrected, even though such revision was, and continues to be, immaterial to the prior year financial statements. Correcting prior year financial statements for immaterial errors would not require previously filed reports to be amended. Such correction should be made in the current period filings. We are currently evaluating the impact of adopting SAB 108. ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK We are exposed to market risks related to changes in U.S. and international interest rates. All of the Company's long-term obligations bear interest at a variable rate. We have no history of, and do not anticipate in the future, investing in derivative financial instruments, derivative commodity instruments or other such financial instruments. Transactions with international customers are entered into in U.S. dollars, precluding the need for foreign currency hedges. As a result, our exposure to market risk is not material. ITEM 4. CONTROLS AND PROCEDURES Our Chief Executive Officer and Chief Financial Officer (collectively, the "Certifying Officers") are responsible for establishing and maintaining disclosure controls and procedures for the Company. The Certifying Officers have concluded (based upon their evaluation of these controls and procedures as of the end of the period covered by this report) that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules of the Securities and Exchange Commission. The Certifying Officers also have indicated that there were no significant changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 19 PART II. - OTHER INFORMATION Item 1. Legal Proceedings Refer to Item 3 (Legal Proceedings) in the Company's Annual Report on Form 10-K for the year ended December 31, 2005. Item 1A. Risk Factors In addition to the other information set forth in this report, including the important information in "Private Securities Litigation Reform Act," you should carefully consider the "Risk Factors" discussed in our Annual Report on Form 10-K for the year ended December 31, 2005. Those factors, if they were to occur, could cause our actual results to differ materially from those expressed in our forward-looking statements in this report, and materially adversely affect our financial condition or future results. Although we are not aware of any other factors that we currently anticipate will cause our forward-looking statements to differ materially from our future actual results, or materially affect the Company's financial condition or future results, additional risks and uncertainties not currently known to us or that we currently deem to be immaterial might materially adversely affect our actual business, financial condition and/or operating results. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds None Item 3. Defaults Upon Senior Securities None. Item 4. Submission of Matters to a Vote of Security Holders None. Item 5. Other Information None. Item 6. Exhibits (a) Exhibits - See Exhibit Index on page following signatures 20 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: November 14, 2006 HEALTH FITNESS CORPORATION By /s/ Jerry V. Noyce ------------------------------------------ Jerry V. Noyce Chief Executive Officer (Principal Executive Officer) By /s/ Wesley W. Winnekins ------------------------------------------ Wesley W. Winnekins Chief Financial Officer (Principal Financial and Accounting Officer) 21 EXHIBIT INDEX HEALTH FITNESS CORPORATION FORM 10-Q Exhibit No. Description ----------- -------------------------------------------------------------- **11.0 Statement re: Computation of Earnings per Share **31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 **31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 **32.1 Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 **32.2 Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 ---------- * Indicates management contract or compensatory plan or arrangement ** Filed herewith 22